+ ) emission tomography (PET) is a powerful, noninvasive tool for the in vivo, three-dimensional imaging of physiological structures and processes. PET imaging involves the incorporation of short-lived radionuclides, particularly carbon-11 and fluorine-18, into biologically active molecules. The resulting radiopharmaceuticals are introduced into human subjects, liberating positrons in the decay process that subsequently annihilate with electrons in adjacent matter. Detection of the g radiation generated during annihilation allows for well-defined images of ongoing bodily processes to be obtained. Understandably, wielding this technologywhich requires the manipulation of strong radioemitters, short end-product efficacy timeframes, and rigorous quality control-is not a simple undertaking. In answer to this, and speaking to its clinical value, research pertaining to PET has observed exciting and rapid growth.
The prospective applications for PET imaging are innumerable.
[1] Exploiting PET to its fullest potential has been limited, however, in large part, by the availability of pertinent radiopharmaceuticals. The identification of a suitable radionuclide for use in labeling is a concern intrinsic to the preparation of radiopharmaceutical agents. Carbon-11 and fluorine-18 are commonly used and each has its own merits. Radiolabeling with 11 C has advantages that include minimal effects on substrate biological activity and ease of incorporation.
11 C-radiolabeling also affords the ability to run multiple scans per day in series. However, 11 C suffers from a rather short half-life (20 min) and susceptibility to environmental 12 C contamination in processing.
[2] 18 F finds utility in light of the fact that its incorporation into bioactive species sometimes affects their pharmacological profile. Fluorine-18 offers the benefit of a substantial half-life (about 110 min, allowing for distribution to satellite PET scan facilities), a clean decay process (97 % b + emission) and limited positron migration (about 1 mm, leading to highly resolved images A number of reports describing improved methods and substrates for nucleophilic fluorination have recently appeared in the literature. Gouverneur and co-workers described a protocol for palladium-catalyzed allylic fluorination [6] that well represents the adaptation of modern synthetic methods for radiochemical synthesis. Allyl 4-nitrophenyl carbonates were smoothly converted to their corresponding allylic fluorides on treatment with TBAF·(tBuOH) 4 in the presence of catalytic Pd(dba) 2 (TBAF = tetrabutylammonium fluoride, dba = dibenzylideneacetone, Scheme 4). The method was then evaluated within the time constraints presented by radionuclide handling. Nitrophenyl cinnamyl carbonate 6 gave the corresponding fluoride 7 in 7 % radiochemical yield (RCY); higher conversions (10-52 % RCY) were observed using methyl cinnamyl carbonate as substrate under prolonged reaction times (30 min). Satisfactory yields were also obtained comparing the protocol to direct S N 2 18 F fluorination. Subjecting cinnamyl bromide to the system for 5 min at room temperature gave 20 % RCY of the corresponding fluoride. Forcing conditions (110 8C, 20 min) generated cinnamyl fluoride in 40 and 42 % RCY from cinnamyl chloride and bromide, respectively. Interestingly, products of competitive S N 2' displacement, which are sometimes evident in direct substitution methods, were not detected in the Pd-mediated variant.
Novel substrates for nucleophilic aromatic substitution (S N Ar) have recently been a topic of investigation relevant to [ 18 F] fluorination. Symmetric and asymmetric diaryliodonium salts of target precursors, in particular, have received attention owing to their ease of preparation and compatibility with moderately electronic-rich arene systems. [7] For example, Coenen and co-workers have disclosed aryl(2-thienyl)iodonium salts as substrates of 18 F À for S N Ar which show enhanced reactivity at electron-rich homoarenes (Scheme 5 a). [8] Similarly, Pike and co-workers have shown the utility of diaryliodonium tosylates in the synthesis of mGluR5 PET radioligands (Scheme 5 b). [9] Advances in this area have significantly expanded the scope of classical S N Ar beyond electrondeficient arenes, to the benefit of 18 F radiochemistry. Direct incorporation of the 18 F radionuclide by either nucleophilic or electrophilic substitution is frequently employed for the preparation of radiopharmaceuticals. Substrates that are not poised for direct 18 F modification, however, are a common hindrance to the synthetic radiochemist. Bimolecular reactions joining reactive 18 F-labeled small molecule prosthetic groups with a ligand of interest-or Angewandte Chemie "indirect 18 F fluorination"-provide alternative means for accessing radiopharmaceuticals.
[ 18 F]Fluoroazides have found increasing utility as prosthetic groups in 18 F radiochemistry through the azide-alkyne 1,3-dipolar (Huisgen) cycloaddition. [10] Advances in the Huisgen cycloaddition for PET increasingly have had to take into account considerations of intellectual property and the potential for cytotoxic transition-metal contamination in clinic-bound radiotracers. [11] To circumvent the complications presented by copper contamination, Feringa et al. recently described applications of copper-free click chemistry promoted by strained aza-cyclooctynyl species for 18 F radiochemistry. [12] [ 18 F]Azide 8 was incubated with azacyclooctyne-modified bombesin 9 (Scheme 6) at ambient temperature for 15 min (Scheme 5). A satisfactory radiochemical yield was observed in this first example of 18 Fradiolabeling through copper-free alkyne-azide [3+2] cycloaddition.
Other innovative [
18 F]fluorine-containing reagents for radiopharmaceutical preparation have recently been disclosed. Cognizant that the trifluoromethyl is a privileged motif in small molecule drugs, Riss and Aigbirhio reported a technique for the synthesis of 1-[
18 F]fluoro-1,1-difluoromethyl groups. [13] A simple and efficient procedure for the preparation of 2-[
18 F]fluoro-2,2-difluoroethyltosylate 11 was outlined, beginning from the difluorovinylsulfonate 10 (Scheme 7). The resulting [
18 F]fluoroethylating agent proved effective for O-and N-alkylation, giving rise to the neurofibrillar tangle imaging agent 12 and the tropane derivative 13, respectively.
Gouverneur and co-workers recently showed that 4-[
18 F]fluorobenzaldehydes are efficient vehicles for 18 F delivery in classical multicomponent reactions. [14] Overcoming substoichiometric quantities of 4-[
18 F]fluorobenzaldehyde 14 versus other reaction participants and prolonged reaction times witnessed in "cold" studies, radio-Groebke-BienaymØ-Blackburn reactions were successfully executed (Scheme 8). Not illustrated here for the sake of brevity, Ugi, Passerini, and Biginelli reactions were also carried out in good to excellent radiochemical yields. Notably, the 3,4-dihydropyrimidin-2-(1H)-ones, imidazo[1,2-a]pyridines and a-acyloxyamides obtained by these methods featured 18 F substituents not available by conventional direct S N Ar techniques.
In answer to the increasing demand for novel radiopharmaceuticals, a number of research groups have initiated programs directed toward the development of new radiolabeling methods. This global effort has brought to bear an impressive range of methods and reactions for 18 .
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